| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $5.72B | $5.81B | $4.90B | $3.43B | $4.48B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $406.57M | $411.88M | $148.75M | – | – |
| SG&A | $322.09M | $274.67M | $231.13M | $423.72M | $506.24M |
| Operating Income | -$5.94B | $1.83B | – | – | – |
| Interest Expense | – | $0.00 | $13.12M | – | – |
| Tax Expense | -$97.11M | $279.18M | $565.16M | $300.51M | $170.19M |
| Net Income | $54.53M | $1.58B | $2.08B | $1.19B | $1.03B |
| EPS (basic) | 0.3142 | 9.1327 | 11.7692 | 6.8397 | 6.1113 |
| EPS (diluted) | 0.3122 | 9.0566 | 11.6415 | 6.8126 | 6.0554 |
| Shares (diluted) | $174.68M | $174.71M | $178.69M | $175.39M | $170.59M |